The tariff classification of Glipizide Tablets in dosage form, from Spain
Issued February 14, 2023 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9291
Headings: 3004
Product description
Glipizide, imported in 5 mg and 10 mg tablets, is an anti-diabetic medication of the sulfonylurea class. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
CBP rationale
The applicable subheading for the Glipizide Tablets in dosage form will be 3004.90.9291, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.
Full text
N330463 February 14, 2023 CLA-2-30:OT:RR:NC:N3 138 CATEGORY: Classification TARIFF NO.: 3004.90.9291 Carol Glenny Avila NorthStar Healthcare UC 3300 Cork Airport Business Park, Kinsale Road Cork T12 XN72 Ireland RE: The tariff classification of Glipizide Tablets in dosage form, from Spain Dear Ms. Glenny Avila: In your letter dated January 24, 2023, you requested a tariff classification ruling. Glipizide, imported in 5 mg and 10 mg tablets, is an anti-diabetic medication of the sulfonylurea class. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The applicable subheading for the Glipizide Tablets in dosage form will be 3004.90.9291, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/current. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification and country of origin of Methylene Blue Injection, USP in dosage form
The tariff classification of Dapagliflozin Tablets in dosage form, from India
The tariff classification of Linagliptin and Metformin Hydrochloride Tablets and Linagliptin Tablets in dosage form, from India
The tariff classification of Miglustat Capsules in dosage form, from India
The tariff classification of Repaglinide Tablets in dosage form, from India
The tariff classification of Tranexamic Acid in dosage form, from China
The tariff classification of Allopurinol Tablets in dosage form, from India
The tariff classification of Varenicline Tartrate Tablets in dosage form, from India
The tariff classification of Fesoterodine Fumarate Extended-Release Tablets in dosage form, from India
The tariff classification of Deferasirox Tablets in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →